Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development: Proceedings of a Workshop [Prepublication Draft].

Those involved in the drug development process face challenges of efficiency and overall sustainability due in part to high research costs, lengthy development timelines, and late-stage drug failures. Novel clinical trial designs that enroll participants based on their genetics represent a potentially disruptive change that could improve patient outcomes, reduce costs associated with drug development, and further realize the goals of precision medicine.

http://ift.tt/2ufQlwP